Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

2-methoxymethyl-2-hydroxymethyl-1-azabicyclo[2,2,2]octan-3-one

EU orphan designation number: EU/3/10/742   
Active ingredient: 2-methoxymethyl-2-hydroxymethyl-1-azabicyclo[2,2,2]octan-3-one
Indication: Treatment of acute myeloid leukaemia
Sponsor: Aprea Therapeutics AB
Karolinska Institutet Science Park, Nobels väg 3, 171 65 Solna, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/06/2010 Orphan designation EMEA/OD/147/09 (2010)3908 of 10/06/2010
09/03/2017 Change of name and/or address of sponsor